Dvorah 16 mg / 325 mg / 30 mg Oral Tablet
RxNorm 2105929
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2105929 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Dvorah 16 mg / 325 mg / 30 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Acetaminophen 325 mg / caffeine 30 mg / dihydrocodeine bitartrate 16 mg Oral Tablet [Dvorah]
(Atom ID: 12372069)
SY
Synonym (SY):
APAP 325 mg / Caffeine 30 mg / dihydrocodeine bitartrate 16 mg Oral Tablet [Dvorah]
(Atom ID: 10783407)
SY
Synonym (SY):
Dvorah (acetaminophen 325 mg / caffeine 30 mg / dihydrocodeine bitartrate 16 mg) Oral Tablet
(Atom ID: 10782413)
PSN